COMMUNIQUÉS West-GlobeNewswire

Aquestive Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
13/05/2026
Reaffirms guidance to resubmit Anaphylm™ (dibutepinephrine) sublingual film NDA in Q3 2026 Affirms existing clinical data is sufficient for submitting regulatory applications in Canada, European Union, and the United [...]
Journey Medical Corporation Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
13/05/2026
Total revenues for the first quarter ended March 31, 2026 increased 21% year-over-year to $16.0 million Emrosi ® revenues were $6.3 million in the first quarter ended March 31, 2026 Cash position increased to $27 [...]
Bionano Reports First Quarter 2026 Results and Provides a Business Update
13/05/2026
Conference call today, May 13, 2026, at 4:30 PM ET SAN DIEGO, May 13, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the first quarter ended March 31, 2026. "The [...]
MacroGenics Reports First Quarter 2026 Financial Results and Highlights Business Transformation
13/05/2026
Manufacturing operations divestiture sharpens focus on core capabilities in novel drug discovery and development Manufacturing divestiture and expanded monetization of ZYNYZ royalty anticipated to provide up to $202.5 [...]
Aptose Reports First Quarter 2026 Results
13/05/2026
SAN DIEGO and TORONTO, May 13, 2026 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (TSX: APS and OTC: APTOF), a clinical-stage precision oncology company developing a tuspetinib (TUS)-based [...]
Combined General Meeting of June 3, 2026
13/05/2026
Châtillon, France, May 13, 2026 Combined General Meeting of June 3, 2026 Procedures for Obtaining Information and Preparatory Documents for the Combined General Meeting DBV Technologies (Euronext: DBV – ISIN: [...]
ZyVersa Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
13/05/2026
ZyVersa is advancing a highly differentiated pipeline focusing on inflammatory and renal diseases with a total accessible market >$100 billion. Inflammasome ASC Inhibitor IC 100 is the next evolution of inflammasome [...]
Wave Life Sciences to Present at 2026 RBC Capital Markets Global Healthcare Conference
13/05/2026
CAMBRIDGE, Mass., May 13, 2026 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, today [...]
IMDX Reports Q1 2026 Results and Update on Progress Toward GraftAssure Commercialization
13/05/2026
Progressing toward commercialization with third-party head-to-head data publications and GALACTIC registry study engagement Northeast kidney transplant center (among the top 10 in the U.S.) is first to sign clinical [...]
aTyr Pharma to Participate in Upcoming Investor Conferences
13/05/2026
SAN DIEGO, May 13, 2026 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA [...]
Hard Chews Gummies Claims Evaluated: Investigating the Salt Tonic Trick Recipe for Men
14/05/2026
Hard Chews Gummies Ingredients, Male Performance Support, L-Arginine, Tongkat Ali, Maca Root, 180-Day Guarantee, Pricing, and Subscribe and Save Researched Aurora, CO, May 13, 2026 (GLOBE NEWSWIRE) -- These statements [...]
Tango Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Highlights
13/05/2026
First clinical data from PRMT5/RAS(ON) combination trial to be pre sented in 2026 Cash position of $380 million as of March 31, 2026, with runway into 2028 beyond anticipated key data inflection points BOSTON, May 13, [...]
vTv Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
13/05/2026
Phase 3 CATT1 completion of enrollment on track for the third quarter of 2026 Strong balance sheet expected to fund operations through anticipated CATT1 topline data readout HIGH POINT, N.C., May 13, 2026 (GLOBE [...]
Eledon Pharmaceuticals Reports First Quarter 2026 Financial Results and Recent Business Highlights
13/05/2026
100% insulin independence achieved in 10 patients with type 1 diabetes treated with tegoprubart following islet transplantation in UChicago Medicine-led study FDA Orphan Drug designation granted to tegoprubart for the [...]
Rapid Micro Biosystems Reports First Quarter 2026 Financial Results
13/05/2026
Reports first quarter 2026 total revenue of $8.0 million , representing 11% growth compared to the first quarter of 2025 Placed 6 Growth Direct systems in the first quarter 2026 compared to 3 systems in the first [...]
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
13/05/2026
COPENHAGEN, Denmark, May 13, 2026 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the Company’s shares/related securities by persons holding managerial [...]
LogicMark, Inc. Announces Strong First Quarter 2026 Results
13/05/2026
Revenue Up 24% as Gross Margin Expands to 69.6% and Operating Loss Narrows LOUISVILLE, Ky., May 13, 2026 (GLOBE NEWSWIRE) -- LogicMark, Inc. (OTC: LGMK) (the “Company”), a provider of personal safety and emergency [...]
Dyadic Announces First Quarter 2026 Financial Results and Highlights Recent Company Progress
13/05/2026
Received initial purchase orders for recombinant bovine transferrin from customers in the cultivated meat industry Commercial launch of AlbuFree™ DX recombinant human albumin by Proliant Health & Biologicals using [...]
Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences
13/05/2026
SAN DIEGO, May 13, 2026 (GLOBE NEWSWIRE) -- Zentalis ® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical oncology innovator advancing late-stage development of investigational first-in-class WEE1 inhibitor azenosertib as [...]

Pages